Neurotransmitter Balance Assessment is the clinical evaluation aimed at determining the relative concentrations and functional availability of key neuromodulators, such as catecholamines, indolamines, and amino acid derivatives, within the body’s signaling pools. Achieving balance is vital because these chemicals mediate mood, stress response, and cognitive performance, often interacting closely with the endocrine system. This assessment helps pinpoint chemical contributors to symptomatic presentations. We are mapping the brain’s chemical communication network.
Origin
This field originates from psychoneuroendocrinology, where the interaction between brain chemistry and hormonal regulation was first formalized. The assessment seeks to quantify the dynamic equilibrium between excitatory and inhibitory signals. The term ‘balance’ is preferred over ‘level’ to emphasize the importance of ratios for optimal function.
Mechanism
The mechanism involves analyzing metabolites of neurotransmitters in plasma or urine, which serve as proxies for central nervous system activity, or direct measurement of precursors. Deficits in one pathway can often be exacerbated by imbalances in others, such as low GABA activity relative to excitatory glutamate. Furthermore, sex hormones directly influence the synthesis and receptor sensitivity of these neurotransmitters, linking this assessment intrinsically to hormonal health.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.